TABLE 1

Prevalence and demographic characteristics of viral hepatitis markers among patients with jaundice who tested negative for yellow fever in the DRCa

CharacteristicHBV surface Agb (n = 470)Anti-HBcc IgM (n = 444)HDV Ag + total Abd (n = 84)HCV Ag + total Ab (n = 379)HAV IgM (n = 432)HEV IgM (n = 365)
Overall prevalence (% [95% CI])22.3 (18.5–26.0)11.0 (8.1–13.9)26.1 (16.6–35.5)2.3 (0.8–3.8)16.7 (13.2–20.2)10.4 (7.3–13.5)
Sex (female/male, 0.8:1)
    Male65/257 (25.2)23/243 (9.4)13/49 (26.5)5/201 (2.4)39/233 (16.7)25/195 (12.8)
    Female40/213 (18.7)26/201 (12.9)9/35 (25.7)4/178 (2.2)33/199 (16.5)13/170 (7.6)
Age (mean, 22.4 yr; range, 4 mo to 77 yr)
    0–5 yr13/118 (11)7/107 (6.5)2/10 (20)2/90 (2.2)46/108 (42.5)0/87 (0)
    6–15 yr14/78 (17.9)6/76 (7.8)2/12 (16.6)0/64 (0)21/74 (28.3)2/67 (2.9)
    16–40 yr59/184 (32)29/176 (16.4)12/45 (26.6)3/146 (2)4/166 (2.4)22/142 (15.4)
    >40 yr19/90 (21.1)7/85 (8.2)6/17 (35.2)4/79 (5)1/84 (1.1)14/69 (20.2)
Province of origin
    Bandundu9/34 (26.4)8/34 (23.5)0/8 (0)0/22 (0)4/32 (12.5)0/29 (0)
    Bas-Congo4/14 (28.5)2/13 (15.3)0/3 (0)0/10 (0)5/13 (38.4)0/11 (0)
    Equateur31/121 (25.6)11/112 (9.8)9/27 (33.3)1/99 (1)12/116 (10.3)28/98 (28.5)
    Kasai-Occidental12/48 (25)7/47 (14.8)0/13 (0)1/31 (3.2)4/45 (8.8)8/37 (21.6)
    Kasai-Oriental9/52 (17.3)6/54 (11.1)1/8 (12.5)1/40 (2.5)8/54 (14.8)1/44 (2.2)
    Katanga0/6 (0)0/6 (0)0/00/6 (0)0/6 (0)0/3 (0)
    Kinshasa3/21 (14.2)2/21 (9.5)1/2 (50)0/14 (0)4/21 (19)0/15 (0)
    Maniema0/11 (0)0/11 (0)0/01/10 (10)2/11 (18.1)0/9 (0)
    Nord-Kivu0/11 (0)0/11 (0)0/00/10 (0)1/11 (9)0/11 (0)
    Orientale37/152 (24.3)13/135 (9.6)11/23 (47.8)5/137 (3.6)32/123 (26)1/108 (0.9)
  • a Data are number of samples testing positive/total number of antibodies tested (%) unless stated otherwise.

  • b Ag, antigen.

  • c Hbc, hepatitis B core protein.

  • d Ab, antibody.